Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

  Paper Title

``DRUG DESIGN STRATEGY AND CHEMICAL PROCESS MAXIMIZATION IN THE LIGHT OF MOLECULAR HYBRIDIZATION CONCEPT.``

  Authors

  Dr. subhasis Basu

  Keywords

Keywords: Molecular hybridization, Drug design, Hybrid compounds, Pharmacophoric group combination, DNA and RNA Sequencing.

  Abstract


Abstract Molecular hybridization of nucleic acids is the process in which two single-stranded nucleic acid molecules with complementary base sequences form a double-stranded nucleic acid molecule. Nucleic acid hybridization technology is a fundamental tool in molecular biology, and has been applied in various fields such as detection of gene expression, screening specific clone from cDNA or genomic library, determining the location of a gene in chromosome and diagnosis of diseases. Cage like property for eg graphene or glue like bio material from spider or even polymer can bind rapid growth of cell for its binding nature at micro level or can trap bacterial or viral growth by trapping within Net like structure. The idea of Quantum Dots may be implied to identify such net as drug to separate from diseases infected Zone. Sometime electrification or by application of Radioactivity through this net may reduce harmful diseases spreading. Molecular hybridization a useful tool in the design, trapping of new generation drug prototypes using the sequencing of Nucleic acids for a particular patient. Molecular hybridization is a new concept in drug design and development based on the combination of pharmacophoric moieties of different bioactive substances to produce a new hybrid compound with improved affinity and efficacy, when compared to the parent drugs. Additionally, this strategy can result in compounds presenting modified selectivity profile, different and/or dual modes of action and reduced undesired side effects. So, in this paper, we described several examples of different strategies for drug design, discovery and pharmaco modulation focused on new innovative hybrid compounds presenting analgesic, anti-inflammatory, platelet anti-aggregating, anti-infectious, anticancer, cardio- and neuroactive properties. By this molecular hybridization concept in the field of genetic engineering and as well as molecular biology, formation of a partially or wholly complementary nucleic acid duplex as association of single strands, usually between DNA and RNA strands (previously associated or un associated DNA , RNA strands.). These are used to detect an isolated specific genetically initiated sequences as measured sequencing homology, or define other characteristics of one or both strands. If we can detect the particular cause of critical disease like Parkinson, Cancer or AIDS for a particular patient. We can synthesis the new drug design for that patient to treat them for complete cure in this molecular hybridisation concept. So this is a new generation concept for developing drug as well as the cause of the particular diseases for a particular patient. Not only that by fusing more than one drugs structure components by Molecular hybridisation concept we can make a single drug for a patient with multiple affected diseases using computer simulation more modern method in the field of medicinal chemistry. The idea will show us to find the way of sustainable health and immortality in future.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT2012039

  Paper ID - 200764

  Page Number(s) - 284-467

  Pubished in - Volume 8 | Issue 12 | December 2020

  DOI (Digital Object Identifier) -   

  Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Cite this article

  Dr. subhasis Basu,   "``DRUG DESIGN STRATEGY AND CHEMICAL PROCESS MAXIMIZATION IN THE LIGHT OF MOLECULAR HYBRIDIZATION CONCEPT.``", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.8, Issue 12, pp.284-467, December 2020, Available at :http://www.ijcrt.org/papers/IJCRT2012039.pdf

  Share this article

  Article Preview

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper May 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer